LIGAND PHARMACEUTICALS INC·4

Sep 24, 5:10 PM ET

Zimmermann Martine 4

4 · LIGAND PHARMACEUTICALS INC · Filed Sep 24, 2025

Insider Transaction Report

Form 4
Period: 2025-09-22
Transactions
  • Tax Payment

    Common Stock

    2025-09-22$170.77/sh115$19,6394,443 total
Footnotes (1)
  • [F1]Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT